Related Experiment Video
Updated: Jun 21, 2026
10:26
Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
Published on: November 1, 2017
Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)
Pilar Sánchez Henarejos1, Silverio Ros Martínez, Gema R Marín Zafra
1Department of Medical Oncology, Hospital Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain.
Abstract:
Pegylated liposomal doxorubicin (PLD) is a drug whose use is increasingly common. It has been associated with a lower rate of haematologic and cardiac side effects than its nonencapsulated form. However, mucocutaneous toxicity is quite frequent and can be severe. Here we provide a case report of a patient who developed an intertrigolike eruption during treatment with PLD.
